![King C. Lee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
King C. Lee
Nessuna posizione attualmente
Storia della carriera di King C. Lee
Precedenti posizioni note di King C. Lee
Società | Posizione | Inizio | Fine |
---|---|---|---|
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Consigliere Generale | 01/01/1996 | 01/01/2001 |
IBEX TECHNOLOGIES | Direttore Tecnico/Scientifico/R&S | 01/01/1993 | 01/01/1996 |
Consigliere Generale | 01/01/1993 | 01/01/1996 | |
Wyeth-Ayerst Research | Corporate Officer/Principal | 01/01/1985 | 01/01/1986 |
Eastern Kentucky University | Corporate Officer/Principal | - | - |
ACORDA THERAPEUTICS, INC. | Consigliere Generale | - | - |
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Direttore Tecnico/Scientifico/R&S | 29/01/2010 | 29/01/2010 |
Consigliere Generale | - | - |
Formazione di King C. Lee
University of Kentucky | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Canada | 2 |
Posizioni
General Counsel | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ACORDA THERAPEUTICS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Vion Pharmaceuticals, Inc.
![]() Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
IBEX Technologies, Inc.
![]() IBEX Technologies, Inc. Medical SpecialtiesHealth Technology IBEX Technologies, Inc. manufactures and markets enzymes for biomedical use. The firm also specializes in the custom aliquoting, filling, and lyophilization of enzymes in diagnostic disposables for medical devices. Its products include glycobiology enzymes from flavobacterium heparinum, collagen assays, collagen antibodies, and diamine oxidase liquid. The company was founded by Robert A. Heft on April 10, 1972 and is headquartered in Montréal, Canada. | Health Technology |
Wyeth-Ayerst Research |
- Borsa valori
- Insiders
- King C. Lee
- Esperienza